Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the publication of new research identifying a novel, single-gene target…
Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics
